secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001140361-23-031184
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharma shareholders elect directors, ratify auditor, approve say-on-pay at annual meeting
--------------------------------------------------------------------------------

- Nine directors elected; average support ~97% of votes cast (excluding broker non-votes).
- EisnerAmper LLP ratified as independent auditor for FY 2023 with 70.8M for, 901.6K against.
- Non-binding say-on-pay approved: 53.8M for, 10.5M against, 18.4K abstentions.
- Meeting held June 22, 2023; ~89% of outstanding shares represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036123031184/0001140361-23-031184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036123031184/brhc20054840_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-031184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer